Literature DB >> 30137676

Hepatitis B Virus Core Variants, Liver Fibrosis, and Hepatocellular Carcinoma.

Gaetan Ligat1,2, Catherine Schuster1,2, Thomas F Baumert1,2,3,4.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30137676      PMCID： PMC6324981          DOI： 10.1002/hep.30231

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.298


× No keyword cloud information.
  10 in total

Review 1.  Natural history of acute and chronic hepatitis B: The role of HBV genotypes and mutants.

Authors:  Chih-Lin Lin; Jia-Horng Kao
Journal:  Best Pract Res Clin Gastroenterol       Date:  2017-05-05       Impact factor: 3.043

Review 2.  Hepatitis B virus genotypes and variants.

Authors:  Chih-Lin Lin; Jia-Horng Kao
Journal:  Cold Spring Harb Perspect Med       Date:  2015-05-01       Impact factor: 6.915

Review 3.  Hepatitis B virus infection.

Authors:  Christian Trépo; Henry L Y Chan; Anna Lok
Journal:  Lancet       Date:  2014-06-18       Impact factor: 79.321

4.  Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD.

Authors:  Hannes Hagström; Patrik Nasr; Mattias Ekstedt; Ulf Hammar; Per Stål; Rolf Hultcrantz; Stergios Kechagias
Journal:  J Hepatol       Date:  2017-08-10       Impact factor: 25.083

Review 5.  Mechanisms of HBV-induced hepatocellular carcinoma.

Authors:  Massimo Levrero; Jessica Zucman-Rossi
Journal:  J Hepatol       Date:  2016-04       Impact factor: 25.083

6.  Hepatocellular Carcinoma Risk in Alaska Native Children and Young Adults with Hepatitis B Virus: Retrospective Cohort Analysis.

Authors:  Prabhu P Gounder; Lisa R Bulkow; Mary Snowball; Susan Negus; Philip R Spradling; Brian J McMahon
Journal:  J Pediatr       Date:  2016-08-30       Impact factor: 4.406

7.  Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease.

Authors:  S Günther; N Piwon; A Iwanska; R Schilling; H Meisel; H Will
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

8.  Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication.

Authors:  T F Baumert; S A Rogers; K Hasegawa; T J Liang
Journal:  J Clin Invest       Date:  1996-11-15       Impact factor: 14.808

9.  Incidence of hepatocellular carcinoma according to hepatitis B virus genotype in Alaska Native people.

Authors:  Lance K Ching; Prabhu P Gounder; Lisa Bulkow; Philip R Spradling; Michael G Bruce; Susan Negus; Mary Snowball; Brian J McMahon
Journal:  Liver Int       Date:  2016-04-06       Impact factor: 5.828

10.  An Association Between Core Mutations in Hepatitis B Virus Genotype F1b and Hepatocellular Carcinoma in Alaskan Native People.

Authors:  Sanae Hayashi; Anis Khan; Brenna C Simons; Chriss Homan; Takeshi Matsui; Kenji Ogawa; Keigo Kawashima; Shuko Murakami; Satoru Takahashi; Masanori Isogawa; Kazuho Ikeo; Masashi Mizokami; Brian J McMahon; Yasuhito Tanaka
Journal:  Hepatology       Date:  2018-12-10       Impact factor: 17.425
  10 in total
  8 in total

1.  Oxymatrine attenuates arsenic-induced endoplasmic reticulum stress and calcium dyshomeostasis in hepatic stellate cells.

Authors:  Huiqun Wang; Bing Han; Nanlan Wang; Yang Lu; Ting Gao; Zihan Qu; Hongmei Yang; Qin Yang
Journal:  Ann Transl Med       Date:  2020-09

2.  Prediction for HBsAg seroconversion in children with chronic hepatitis B.

Authors:  Yan-Wei Zhong; Yan-Min Shi; Fang Chu; Jie Liu; Ce Shi; Jiao-Jiao Xu; Peng Liu; Yan-Jie Bai; Xiao-He Xiao; Xiu-Chang Zhang; Min Zhang
Journal:  BMC Infect Dis       Date:  2021-12-04       Impact factor: 3.090

3.  Key pathways and genes in hepatitis B virus-related liver inflammation: Expression profiling and bioinformatics analysis.

Authors:  Jing-Yuan Zhao; Zhao-Zhong Zhong; Li-Yun Zhao; Wen Li
Journal:  Medicine (Baltimore)       Date:  2022-08-26       Impact factor: 1.817

Review 4.  The emerging roles of TRIM21 in coordinating cancer metabolism, immunity and cancer treatment.

Authors:  Xintian Chen; Menghan Cao; Pengfei Wang; Sufang Chu; Minle Li; Pingfu Hou; Junnian Zheng; Zhongwei Li; Jin Bai
Journal:  Front Immunol       Date:  2022-09-09       Impact factor: 8.786

5.  DNA methylation biomarkers for hepatocellular carcinoma.

Authors:  Guorun Fan; Yaqin Tu; Cai Chen; Haiying Sun; Chidan Wan; Xiong Cai
Journal:  Cancer Cell Int       Date:  2018-09-17       Impact factor: 5.722

6.  Serum cytoskeleton-associated protein 4 as a biomarker for the diagnosis of hepatocellular carcinoma.

Authors:  Yu Wang; Weixin Yu; Mingqing He; Yan Huang; Mingyue Wang; Jinzhou Zhu
Journal:  Onco Targets Ther       Date:  2018-12-31       Impact factor: 4.147

7.  Association of Hepatitis B Virus DNA Level and Follow-up Interval With Hepatocellular Carcinoma Recurrence.

Authors:  Wei Wang; Shilin-L Tian; Hui Wang; Chun-Chun Shao; Yong-Zheng Wang; Yu-Liang Li
Journal:  JAMA Netw Open       Date:  2020-04-01

Review 8.  Multiple Roles for Hepatitis B and C Viruses and the Host in the Development of Hepatocellular Carcinoma.

Authors:  Kirk J Wangensteen; Kyong-Mi Chang
Journal:  Hepatology       Date:  2020-11-07       Impact factor: 17.425
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.